Results 161 to 170 of about 108,448 (307)
Objectives This study aimed to ascertain the effect of secukinumab on erosion and enthesiophyte progression in psoriatic arthritis (PsA) by high‐resolution peripheral quantitative computed tomography (HR‐pQCT). Methods This was a phase 4, double‐blind, randomized, placebo‐controlled trial.
Yingzhao Jin+11 more
wiley +1 more source
Food Allergy—Lessons from Asia
Objective This is a review on published data available on food allergy in East Asia and a discussion on the insights that it offers.Methods PubMed searches were made for terms food allergy and anaphylaxis, in combination with Asia.Results There is a ...
Bee Wah Lee+4 more
doaj
Sex‐Based Disparities in Sinonasal Outcomes: A Population‐Based Study
International Forum of Allergy &Rhinology, EarlyView.
Victoria S. Lee+5 more
wiley +1 more source
Objective To assess the incidence of major adverse cardiovascular events (MACE) in RA patients treated with JAKi, TNF‐inhibitors (TNFi) or biologic Disease‐Modifying Anti‐Rheumatic Drugs with other modes of action (bDMARD‐OMA) in a multi‐country, real‐world population.
Romain Aymon+28 more
wiley +1 more source
Food allergy and nutrition in early life: implications for later health [PDF]
Ranjit Kumar Chandra
openalex +1 more source
Understanding factors that influence the drug choice of prescribers: A Q‐methodology study
Abstract Introduction Therapeutic decision‐making often involves weighing several treatment options on the basis of, among other things, the disease profile, patient characteristics but also prescriber‐specific factors. This study investigated the factors influencing therapeutic decision‐making among prescribers and explores how these factors differ ...
Mariëlle G. Hartjes+5 more
wiley +1 more source
Abstract Objective The aim of this study was to collect prospective national data on early‐onset eating disorders (EOEDs) in children in Australia to document changes in clinical presentations, medical complications, management, and incidence since initially described in 2002–2005. Method Each month pediatricians reported children aged 5–13 years newly
Anne Morris+2 more
wiley +1 more source
Abstract Aim TAS5315 is a Bruton tyrosine kinase (Btk) inhibitor in development for autoimmune and allergic diseases, including rheumatoid arthritis (RA) and chronic spontaneous urticaria (CSU). Two clinical studies evaluated the pharmacology and safety of single and multiple oral doses of TAS5315.
Yuji Kumagai+4 more
wiley +1 more source